ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 697535 Null 0.0352028253287042 0.63345533
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0352028253287042 0.33769552
NSC 718630 Null 0.0352028253287042 0.46733773
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 -0.10743196
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0352028253287042 -0.17788803
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0352028253287042 0.38172135
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0352028253287042 -0.0094493263
NSC 730691 Null 0.0352028253287042 0.51086195
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0352028253287042 0.38325908
NSC 733476 Null 0.0352028253287042 0.30753617
Total:151  Current:118    [First] [Prev] [Next] [Last]